BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37271295)

  • 1. Role of mesenchymal stem cells and short chain fatty acids in allergy: A prophylactic therapy for future.
    Mohanan MM; Shetty R; Bang-Berthelsen CH; Mudnakudu-Nagaraju KK
    Immunol Lett; 2023 Aug; 260():1-10. PubMed ID: 37271295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells in allergic diseases: Current status.
    Li H; Tian Y; Xie L; Liu X; Huang Z; Su W
    Allergol Int; 2020 Jan; 69(1):35-45. PubMed ID: 31445840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of allergen-specific IgE, IgG and IgA in allergic disease.
    Shamji MH; Valenta R; Jardetzky T; Verhasselt V; Durham SR; Würtzen PA; van Neerven RJJ
    Allergy; 2021 Dec; 76(12):3627-3641. PubMed ID: 33999439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma.
    Kapoor S; Patel SA; Kartan S; Axelrod D; Capitle E; Rameshwar P
    J Allergy Clin Immunol; 2012 Apr; 129(4):1094-101. PubMed ID: 22196773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
    Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research Progress in Regulation of Allergic Diseases by Short-Chain Fatty Acids].
    Shi YB; Gao SJ; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):28-34. PubMed ID: 35048596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis.
    Wang M; Zhao N; Wang C; Jin ZB; Zhang L
    Allergy; 2023 Jun; 78(6):1425-1440. PubMed ID: 36975714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of tonsil-derived mesenchymal stem cells in a mouse model of allergic rhinitis.
    Samivel R; Kim EH; Chung YJ; Mo JH
    Am J Rhinol Allergy; 2015; 29(4):262-7. PubMed ID: 26085003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renaissance of the blocking antibody concept in type I allergy.
    Flicker S; Valenta R
    Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal mucosa derived-mesenchymal stem cells from mice reduce inflammation via modulating immune responses.
    Yang C; Li J; Lin H; Zhao K; Zheng C
    PLoS One; 2015; 10(3):e0118849. PubMed ID: 25739057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma.
    Trzil JE; Masseau I; Webb TL; Chang CH; Dodam JR; Cohn LA; Liu H; Quimby JM; Dow SW; Reinero CR
    Clin Exp Allergy; 2014 Dec; 44(12):1546-57. PubMed ID: 25220646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and the allergic response.
    Borish L; Joseph BZ
    Med Clin North Am; 1992 Jul; 76(4):765-87. PubMed ID: 1614234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of airway epithelium cell activation by mesenchymal stromal cells ameliorates house dust mite-induced airway inflammation in mice.
    Duong KM; Arikkatt J; Ullah MA; Lynch JP; Zhang V; Atkinson K; Sly PD; Phipps S
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):615-24. PubMed ID: 25789608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation: the future cure for allergic diseases.
    Tsitoura DC; Tassios Y
    Ann N Y Acad Sci; 2006 Nov; 1088():100-15. PubMed ID: 17192559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases.
    Valenta R; Almo S; Ball T; Dolecek C; Steinberger P; Laffer S; Eibensteiner P; Flicker S; Vrtala S; Spitzauer S; Valent P; Denepoux S; Kraft D; Banchereau J; Lebecque S
    Int Arch Allergy Immunol; 1998 Jul; 116(3):167-76. PubMed ID: 9693264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells in food allergy: Inducing immediate reactions and shaping long-term immunity.
    Oettgen HC
    J Allergy Clin Immunol; 2023 Jan; 151(1):21-25. PubMed ID: 36328809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment.
    Wang SY; Fan XL; Yu QN; Deng MX; Sun YQ; Gao WX; Li CL; Shi JB; Fu QL
    Stem Cell Res Ther; 2017 Jan; 8(1):2. PubMed ID: 28057064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small extracellular vesicles derived from human MSCs prevent allergic airway inflammation via immunomodulation on pulmonary macrophages.
    Fang SB; Zhang HY; Meng XC; Wang C; He BX; Peng YQ; Xu ZB; Fan XL; Wu ZJ; Wu ZC; Zheng SG; Fu QL
    Cell Death Dis; 2020 Jun; 11(6):409. PubMed ID: 32483121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.